NASDAQ: AVBP
Arrivent Biopharma Revenue

Arrivent Biopharma revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVBP annual revenue was $0.0, with N/A growth year-over-year.

AVBP revenue history

Current Revenue
$0.0
Current Earnings
-$80.5M
Current Profit Margin
0%

Be the first to know when AVBP announces revenue.

AVBP Revenue History By Year

AVBP Yearly RevenueAVBP RevenueAVBP ChangeAVBP Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Arrivent Biopharma Revenue FAQ

What was AVBP's revenue last quarter?

Arrivent Biopharma (NASDAQ: AVBP) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Arrivent Biopharma's revenue was $0.00.

What was Arrivent Biopharma's revenue in 2024?

Arrivent Biopharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Arrivent Biopharma make in a day?

Based on Arrivent Biopharma annual revenue for the past two years, AVBP makes an average of $0.00 per day.

What was Arrivent Biopharma's annual revenue growth in the past year?

As of Q2 2025, Arrivent Biopharma's revenue has grown null year over year. Arrivent Biopharma's revenue in the past year totaled $0.00.

How much does Arrivent Biopharma make in a year?

Arrivent Biopharma's revenue by year for the past two years is:
  • Arrivent Biopharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Arrivent Biopharma's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.